Department of Medical Genetics, Kaohsiung Medical University, Kaohsiung, Taiwan; Cancer Center, Kaohsiung Medical University Hospital, Kaohsiung; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan
Received date: May 15, 2012; Accepted date: May 18, 2012; Published date: May 21, 2012
Citation: Chang WC (2012) Genetic Variants of Store-Operated Channels and Human Diseases. J Cell Sci Ther 3:e108. doi: 10.4172/2157-7013.1000e108
Copyright: © 2012 Chang WC. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Visit for more related articles at Journal of Cell Science & Therapy
The functional role of Ca2+ influx in non-excitable cells was elusive for many years. In 1986, Prof. Putney  firstly proposed the concept of capacitative Ca2+ channels (also called store-operated channel). In his model, agonist-mediated empty of intracellular Ca2+ stores triggers the activation of calcium channels. In 1992, a series of patch clamp experiments by Hoth and Penner  identified a Ca2+-selective current that was evoked by intracellular stores. This calcium channel was named “Ca2+ release-activated Ca2+ (CRAC) channels”. However, there were two fundamental questions in the field. First, how is calcium ion detected within the calcium store? Second, what is the gene of store-operated calcium channel? By using siRNA screening, STIM1, an intracellular calcium sensor, was found in 2005 [3,4]. Furthermore, the molecular identification of store-operated calcium channel was emerged based on the studies from two laboratories. Feske et al.  identified ORAI1 as the key protein responsible for store-mediated Ca2+ influx. The loss of function mutation of ORAI1 causes human severe combined immune deficiency (SCID). Approaches of genome-wide RNAi screens in Drosophila cells, Vig et al. , identified CRACM1 (CRAC modulators 1) as a regulator in CRAC currents. Using in vitro cell-based studies, Parekh’s group provided evidence that Ca2+ entry through store-operated calcium channels triggered the generation of the pro-inflammatory signals-LTC4 [7,8]. Animal models revealed the significant roles of STIM1 , ORAI1/CRACM1 in mast cell degranulation  and cancer cell development [11,12].
The first study of a genetic defection ORAI1 in humans was reported by Feske et al. , when a mutation (asparagine 91 to tryptophan) in exon 1 of the ORAI1 gene was detected in SCID patients. Due to the genetic mutation, lymphocytes failed to evoke store-operated calcium signals-mediated cytokines production. Feske’s group further identified three mutations (A103E, L194P and A88SfsX25) in ORAI1 gene that resulted in loss of channel functions . Recently, genetic polymorphisms in ORAI1 have been described. In genetic association studies (136 patients with nephrolithiasis and 500 controls), the C allele carrier of rs12313273 in ORAI1 gene was strongly associated to recurrent stone forming in calcium nephrolithiasis patients . Studies from patients with Ankylosing Spondylitis (AS) indicated a close correlation between haplotypes of ORAI1 (rs12313273 and rs7135617) and the risk of HLA-B27 positive AS . In addition, a large scale of human DNA screening (2,478 DNA samples from Taiwanese and Japanese populations) also suggests the involvement of ORAI1 polymorphisms in the susceptibility of atopic dermatitis . These genetics results, combined with the findings in animal studies as well as cellular studies, suggest ORAI1 might be an important target in immune/inflammatory responses.
In conclusion, the field of store-operated channel has remarkably advanced in the past ten years. With high-throughput genomic screening, we can expect that more exciting findings will be revealed in the near future.